Major depressive disorder

W Marx, BWJH Penninx, M Solmi… - Nature Reviews …, 2023 - nature.com
Major depressive disorder (MDD) is characterized by persistent depressed mood, loss of
interest or pleasure in previously enjoyable activities, recurrent thoughts of death, and …

Molecular pathways of major depressive disorder converge on the synapse

GR Fries, VA Saldana, J Finnstein, T Rein - Molecular Psychiatry, 2023 - nature.com
Major depressive disorder (MDD) is a psychiatric disease of still poorly understood
molecular etiology. Extensive studies at different molecular levels point to a high complexity …

Candidate biomarkers in psychiatric disorders: state of the field

A Abi‐Dargham, SJ Moeller, F Ali… - World …, 2023 - Wiley Online Library
The field of psychiatry is hampered by a lack of robust, reliable and valid biomarkers that can
aid in objectively diagnosing patients and providing individualized treatment …

Major depressive disorder: advances in neuroscience research and translational applications

Z Li, M Ruan, J Chen, Y Fang - Neuroscience bulletin, 2021 - Springer
Major depressive disorder (MDD), also referred to as depression, is one of the most common
psychiatric disorders with a high economic burden. The etiology of depression is still not …

The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders

G Sanacora, Z Yan, M Popoli - Nature Reviews Neuroscience, 2022 - nature.com
Stress is a primary risk factor for several neuropsychiatric disorders. Evidence from
preclinical models and clinical studies of depression have revealed an array of structural …

Replicable brain–phenotype associations require large-scale neuroimaging data

S Liu, A Abdellaoui, KJH Verweij… - Nature Human …, 2023 - nature.com
Numerous neuroimaging studies have investigated the neural basis of interindividual
differences but the replicability of brain–phenotype associations remains largely unknown …

Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments

JH Krystal, AP Kaye, S Jefferson… - Proceedings of the …, 2023 - National Acad Sciences
Ketamine has emerged as a transformative and mechanistically novel pharmacotherapy for
depression. Its rapid onset of action, efficacy for treatment-resistant symptoms, and …

The effect of social capital in mitigating drought impacts and improving livability of Iranian rural households

M Savari, HE Damaneh, HE Damaneh - International Journal of Disaster …, 2023 - Elsevier
The improvement of rural households' livability in drought conditions has always been an
important challenge for all countries, especially developing countries, because consecutive …

Glutamate and GABA homeostasis and neurometabolism in major depressive disorder

A Sarawagi, ND Soni, AB Patel - Frontiers in psychiatry, 2021 - frontiersin.org
Major depressive disorder (MDD) is a leading cause of distress, disability, and suicides. As
per the latest WHO report, MDD affects more than 260 million people worldwide. Despite …

Structural brain correlates in major depression, anxiety disorders and post-traumatic stress disorder: A voxel-based morphometry meta-analysis

M Serra-Blasco, J Radua, C Soriano-Mas… - Neuroscience & …, 2021 - Elsevier
The high comorbidity of Major Depressive Disorder (MDD), Anxiety Disorders (ANX), and
Posttraumatic Stress Disorder (PTSD) has hindered the study of their structural neural …